Futura Medical Developments Limited
Futura Medical Developments Limited, often referred to as Futura Medical, is a pioneering company headquartered in Great Britain. Established in 2001, Futura Medical has made significant strides in the pharmaceutical and medical device industries, focusing primarily on innovative solutions for sexual health and pain management. The company is renowned for its unique transdermal delivery systems, which offer effective treatments with enhanced patient compliance. Futura Medical's flagship product, the MED3000, is a groundbreaking topical gel designed to treat erectile dysfunction, setting it apart in a competitive market. With a commitment to research and development, Futura Medical has positioned itself as a leader in its field, achieving notable milestones in regulatory approvals and clinical trials. Its dedication to innovation continues to drive its success and reputation within the healthcare sector.
DitchCarbon Score
How does Futura Medical Developments Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Futura Medical Developments Limited's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Futura Medical Developments Limited, headquartered in Great Britain, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Futura Medical plc, which may influence its climate-related initiatives and commitments. As of now, Futura Medical Developments Limited has not established any documented reduction targets or climate pledges. This lack of specific commitments may reflect a broader industry context where many companies are still developing their sustainability strategies. Given the absence of reported emissions and reduction initiatives, it is essential for Futura Medical Developments Limited to consider setting measurable targets in line with industry standards, such as those outlined by the Science Based Targets initiative (SBTi), to enhance its climate commitments and transparency.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Futura Medical Developments Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
